Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties. [electronic resource]
- Molecular cancer therapeutics Apr 2005
- 595-602 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1535-7163
10.1158/1535-7163.MCT-04-0274 doi
Antineoplastic Agents--pharmacology Biotinylation Blotting, Western Breast Neoplasms--drug therapy Carcinoma, Hepatocellular--drug therapy Cell Cycle Proteins--metabolism Cell Line, Tumor Cell Proliferation Cell-Free System DNA--chemistry Dual Specificity Phosphatase 1 Flavonoids--pharmacology Flow Cytometry Humans Immediate-Early Proteins--metabolism Immunoprecipitation Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3--metabolism Naphthoquinones--pharmacology Phosphoprotein Phosphatases--metabolism Phosphorylation Protein Phosphatase 1 Protein Tyrosine Phosphatases--metabolism Signal Transduction Time Factors Transfection Tyrosine--chemistry cdc25 Phosphatases--metabolism